ANI Pharmaceuticals, Inc. (ANIP)Kennedy Capital Management LLC added to its stake +80K shares

294K

Shares reported · +80K vs prior quarter

0.48%

Disclosed portfolio weight

$22.6M

Reported value

Holdings as of

Mar 31, 2026

Filed

May 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Apr 1, 2026Company filing · Form 8-K · Auditor changeChanged its auditor“On April 1, 2026, ANI Pharmaceuticals, Inc. (the “Company”) notified EisnerAmper LLP (“EisnerAmper”) that EisnerAmper would be dismissed as the Company’s independent registered public accounting firm.”
2. May 8, 2026Company filing · Form 8-K · ResultsReported its results

What came next

1. May 21, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“of Certain Officers ANI Pharmaceuticals, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) on May 21, 2026. At the Annual Meeting, the stockholders of the Company approved the Company’s Amended and Restated 2022 Stock Incentive Plan (the “Amended 2022 Stock Plan”).”
2. Aug 7, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
3. Aug 19, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 19, 2026, the Board of Directors (the “Board”) of ANI Pharmaceuticals, Inc. (the “Company”) appointed Henry Gosebruch to serve on the Board as a director with a term expiring at the Company’s 2027 annual meeting of stockholders.”

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for ANI Pharmaceuticals, Inc.

For ANI Pharmaceuticals, Inc., OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ANIP page.

How this filing works

• SEC Form 13F

Other disclosures at ANI Pharmaceuticals, Inc.

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRMay 14, 2026
• SEC Form 13F-HRFeb 17, 2026

Everything OQRO holds on this company is on its ANIP page.